Directorio de personas
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grado: Doctor/a

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicaciones

  • Altés, G; Olomí, A; Perramon-Guell, A; Hernandez, S; CASANOVAS, A; Perez, A; Diaz-Tocados, JM; Valdivielso, JM; Megino, C; Navaridas, R; Matias-Guiu, X; Klein, OD; Egea, J; Dolcet, X; Yeramian, A; Encinas, M

    Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice

    SCIENTIFIC REPORTS 14 -. .

    [doi:10.1038/s41598-024-70529-w]

  • León-Mengibar, J; Sánchez, E; Herrerías, F; de la Fuente, MC; Santamaría, M; Valdivielso, JM; Bermúdez-López, M; Castro, E; Pallarés, J; Matias-Guiu, X; VILARDELL, F; Caixàs, A; Bueno, M; Marti, R; Lecube, A

    Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology 15 1366015-1366015. .

    [doi:10.3389/fendo.2024.1366015]

  • Pérez-Gómez, A; Tocados, JMD; Coral, JDD; García-Carrasco, A; Caus, M; Schanstra, J; Del Bello, A; Klein, J; Valdivielso, JM

    PI3K/AKT/mTOR pathway regulates renal expression of Klotho

    NEPHROLOGY DIALYSIS TRANSPLANTATION 39 1192-1192. .

  • Caus, M; Alonso-Montes, C; Fernandez-Martin, JL; Martí-Antonio, M; Sanjuan, AE; Pérez-Gómez, A; Tocados, JMD; Bozic, M; Valdivielso, JM

    Vitamin D receptor from VSMCs regulates vascular calcification during CKD: a potential role for miR-145a

    NEPHROLOGY DIALYSIS TRANSPLANTATION 39 107-107. .

  • Salina-Roca, B; Sánchez, E; Bermúdez-López, M; Valdivielso, JM; Farràs-Sallés, C; Pamplona, R; Torres, G; Mauricio, D; Castro, E; Fernández, E; Hernández, M; Rius, F; Lecube, A

    Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort

    SLEEP MEDICINE 116 19-26. .

    [doi:10.1016/j.sleep.2024.02.032]

  • Carrión-Barberá, I; Triginer, L; Tío, L; Pérez-García, C; Ribes, A; Abad, V; Pros, A; Bermúdez-López, M; Castro-Boqué, E; Lecube, A; Valdivielso, JM; Monfort, J; Salman-Monte, TC

    Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 25 -. .

    [doi:10.3390/ijms25053022]

  • Balafa, O; Fernandez-Fernandez, B; Ortiz, A; Dounousi, E; Ekart, R; Ferro, CJ; Mark, PB; Valdivielso, JM; Del Vecchio, L; Mallamaci, F

    Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

    CLINICAL KIDNEY JOURNAL 17 -. .

    [doi:10.1093/ckj/sfae044]

  • Valdivielso JM; Carriazo S; Martin M; Fernandez-Fernandez B; Bermudez-López M; Ortiz A

    Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men.

    CLINICAL KIDNEY JOURNAL 17 -. .

    [doi:10.1093/ckj/sfad212]

  • Cambray, S; Bermúdez-López, M; Garcia-Carrasco, A; Valdivielso, JM

    Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort

    CLINICAL KIDNEY JOURNAL 17 -. .

    [doi:10.1093/ckj/sfad257]

  • Grams ME; Coresh J; Matsushita K; Ballew SH; Sang Y; Surapaneni A; Alencar de Pinho N; Anderson A; Appel LJ; Ärnlöv J; Azizi F; Bansal N; Bell S; Bilo HJG; Brunskill NJ; Carrero JJ; Chadban S; Chalmers J; Chen J; Ciemins E; Cirillo M; Ebert N; Evans M; Ferreiro A; Fu EL; Fukagawa M; Green JA; Gutierrez OM; Herrington WG; Hwang SJ; Inker LA; Iseki K; Jafar T; Jassal SK; Jha V; Kadota A; Katz R; Köttgen A; Konta T; Kronenberg F; Lee BJ; Lees J; Levin A; Looker HC; Major R; Melzer Cohen C; Mieno M; Miyazaki M; Moranne O; Muraki I; Naimark D; Nitsch D; Oh W; Pena M; Purnell TS; Sabanayagam C; Satoh M; Sawhney S; Schaeffner E; Schöttker B; Shen JI; Shlipak MG; Sinha S; Stengel B; Sumida K; Tonelli M; Valdivielso JM; van Zuilen AD; Visseren FLJ; Wang AY; Wen CP; Wheeler DC; Yatsuya H; Yamagata K; Yang JW; Young A; Zhang H; Zhang L; Levey AS; Gansevoort RT

    Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.

    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 330 1266-1277. .

    [doi:10.1001/jama.2023.17002]

  • Del Vecchio, L; Balafa, O; Dounousi, E; Ekart, R; Fernandez, BF; Mark, PB; Sarafidis, P; Valdivielso, JM; Ferro, CJ; Mallamaci, F

    COVID-19 and cardiovascular disease in patients with chronic kidney disease

    NEPHROLOGY DIALYSIS TRANSPLANTATION 39 177-189. .

    [doi:10.1093/ndt/gfad170]

  • Amaya-Garrido A; Brunet M; Buffin-Meyer B; Piedrafita A; Grzesiak L; Agbegbo E; Del Bello A; Ferrandiz I; Ardeleanu S; Bermudez-Lopez M; Fedou C; Camus M; Burlet-Schiltz O; Massines J; Buléon M; Feuillet G; Alves M; Neau E; Casemayou A; Breuil B; Saulnier-Blache JS; Denis C; Voelkl J; Glorieux G; Hobson S; Arefin S; Rahman A; Kublickiene K; Stenvinkel P; Bascands JL; Faguer S; Valdivielso JM; Schanstra JP; Klein J

    Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease.

    Science Translational Medicine 15 -. .

    [doi:10.1126/scitranslmed.abn5939]

Proyectos

  • Ayudas Juan de la Cierva-formación
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.
  • Caracterización de un perfil lipidomico y lipídico de riesgo aterogénico y de morbimortalidad cardiovascular en la enfermedad renal crónica (estadios 3 a 5) (estudio prospectivo NEFRONA)
  • ADVENTITIAL VASA VASORUM AND SUBCLINICAL ATHEROMATOSIS
  • Papel de la expresión renal de alfa sinucleina en la enfermedad renal crónica. Implicaciones en la patogénesis de la fibrosis renal
  • IDENTIFYING PREDICTORS OF CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. A COHORTS SUBSTUDY WITHIN THE NEFRONA STUDY
  • PAPEL DE LA FALTA DE VITAMINA D EN LA PROGRESION DE LA PLACA ATEROSCLEROTICA. IMPLICACIONES ENF LA ARTERIOPATIA UREMICA
  • REGULACION DE LA SINTESIS VASCULAR DE CALCITRIOL EN CONDICIONES NORMALES EN LA UREMIA. EFECTOS DEL TRATAMIENTO CON VITAMINA D Y ANALOGOS
  • PAPEL DEL RECEPTOR DE VITAMINA D EN LA PROGRESION DEL CICLO CELULAR Y LA SENESCENCIA DE LAS CELULAS DE MUSCULO LISO VASCULAR. IMPLICACIONES EN LA FORMACION DE PLACA DE ATEROMA.
  • ROLE OF VDR ON VASCULAR SMOOTH CELLS BIOLOGY
  • PROGRAMA DE BEQUES PER A PERSONAL INVESTIGADOR NOVELL (FI)
  • REGULACION DEL METABOLISMO VASCULAR DEL CALCITROL EN CONDICIONES NORMALES Y EN LA UREA